Dermovate

Dermovate

clobetasol

Manufacturer:

GlaxoSmithKline Indonesia
Concise Prescribing Info
Contents
Clobetasol propionate
Indications/Uses
Short-course treatment of resistant dermatoses eg, psoriasis (excluding widespread plaque psoriasis), recalcitrant eczema, lichen planus, discoid lupus erythematosus & other conditions which do not respond satisfactorily to less active steroids.
Dosage/Direction for Use
Contraindications
Untreated cutaneous infections, rosacea, acne vulgaris, pruritus w/o inflammation, perianal & genital pruritus, perioral dermatitis. Dermovate is contraindicated in dermatoses in childn <1 yr, including dermatitis.
Special Precautions
Infant & childn especially those w/ adrenal suppression; patients w/ psoriasis. Discontinue in case of exacerbation of infection; face may exhibit atrophic changes on prolonged treatment. Avoid contact w/ eyes. Long-term continuous therapy. Pregnancy.
Adverse Reactions
Pruritus, local skin burning/skin pain.
ATC Classification
D07AD01 - clobetasol ; Belongs to the class of very potent (group IV) corticosteroids. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Dermovate cream 0.05%
Packing/Price
10 g x 1's;5 g x 1's
Form
Dermovate oint 0.05%
Packing/Price
10 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in